Multiple Myeloma

Multiple Myeloma (MM) is the second most common cancer of the blood and accounts for 1% of all malignancies. MM is a very heterogeneous disease from both clinical and molecular point of view. Its pathogenesis remains poorly understood and it is considered an incurable disease. The molecular epidemiology of MM is an exciting area of research. Major advances have been made in recent years highlighting the need to face the disease through common efforts within large cooperative groups. There is a set of accepted risk factors for MM like increasing age, male gender, black race, positive family history or having a Monoclonal Gammopathy Of Uncertain Significance (MGUS). In addition, an emerging group of new risk factors should be taken into consideration. Interestingly, a growing body of evidence points out to obesity as a consistent risk factor for MM. Four metaanalysis have found a positive association between obesity and MM risk. Internal Medicine Open Access, an official journal of OMICS group international publishes all the articles related to multiple Myeloma. The journal is subjecting all the received manuscripts to a strict peer review process. The articles published in the journal are Open Access i.e, freely accessible to readers all around the world. Internal Medicine Open Access is maintaining the quality of articles through its strict peer review process.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on April, 2024